A new study in Scientific Reports examines this area, looking at how the two are related in low- and middle-income countries (LMIC).
Merck kick-starts PhIII cholesterol trials for its oral PCSK9; Baxter recalls 13,000+ vials of chemotherapy
Merck revealed Friday it started up its first late-stage clinical program for an oral PCSK9 inhibitor for cholesterol. The program is currently enrolling participants in